Navigation Links
Sporadic play activity as beneficial to child health as continuous bouts of exercise, study suggests
Date:5/11/2009

New research suggests for the first time that frequent bouts of sporadic activity could be just as beneficial to children's health as longer exercise sessions. A team from the University of Exeter measured the frequency, intensity and duration of bouts of physical activity in a group of children and analysed the results against a number of health indicators.

The results highlighted that the associations between children's activity and health were similar regardless of how the child accumulated the activity. In other words, a child who accumulated short bursts of moderate or vigorous exercise throughout the day was just as healthy as a child who did a similar amount of activity over longer sessions.

The researchers, from the University of Exeter's School of Sport and Health Sciences, believe their findings have positive implications, as children are more likely to engage in short bursts of activity than complete longer bouts of exercise.

Published in the International Journal of Pediatric Obesity, the study focused on 47 boys, aged between eight and ten, the majority of who were all in good health and within a healthy weight range. Using electronic devices called 'accelerometers' worn by the boys, the researchers recorded the frequency, intensity and duration of their activity over seven days. They then conducted a series of tests to measure health indicators, including waist circumference, aerobic fitness and microvascular function (an early indicator of cardiovascular risk).

During a typical day, less than 15% of the boys achieved five bouts of moderate intensity activity lasting five minutes and very few managed to achieve one bout of vigorous intensity activity lasting five minutes. The findings suggest that schools, parents and policy-makers should focus their efforts on encouraging young children to move around as they do naturally.

Lead researcher Michelle Stone, a PhD student at the University of Exet
'/>"/>

Contact: Sarah Hoyle
s.hoyle@exeter.ac.uk
44-139-226-2062
University of Exeter
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. LOH analysis on 4q in sporadic colorectal carcinoma
2. ABCs and No Skinned Knees: Study Reveals Various Barriers to Physical Activity in Child Care
3. NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACR
4. Mersanas Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting
5. Drug shows activity in men with advanced prostate cancer
6. Middle school youth as young as 12 engaging in risky sexual activity
7. A mothers criticism causes distinctive neural activity among formerly depressed
8. GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
9. Heightened level of amygdala activity may cause social deficits in autism
10. Brain abnormality found in boys with attention deficit hyperactivity disorder
11. MIB Life Index Reports North American Life Insurance Activity up 1.1% in February
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Maternal Mortality Declining in Middle-income Countries; Women Still Die in Pregnancy and Childbirth in Low-income Countries 2Health News:Maternal Mortality Declining in Middle-income Countries; Women Still Die in Pregnancy and Childbirth in Low-income Countries 3Health News:Nasdaq Informs Synutra that the Company's Filing Delinquency has been Cured 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 3Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 4Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 5Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 6Health News:American Psychiatric Foundation Hosts a Benefit for New Orleans Mental Health Organizations as a Part of the Institute for Psychiatric Services Conference 2Health News:New research may show why some prostate cancer recurs after treatment 2Health News:New research may show why some prostate cancer recurs after treatment 3Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 2Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 3
Breaking Medicine Technology:Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 2Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 3Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 4Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 5Maxim Health Systems to Provide 44 000 Flu Shot Clinics Nationwide 3B Flu Vaccinations Begin on October 1 56447 1Maxim Health Systems to Provide 44 000 Flu Shot Clinics Nationwide 3B Flu Vaccinations Begin on October 1 56447 2Maxim Health Systems to Provide 44 000 Flu Shot Clinics Nationwide 3B Flu Vaccinations Begin on October 1 56447 3Maxim Health Systems to Provide 44 000 Flu Shot Clinics Nationwide 3B Flu Vaccinations Begin on October 1 56447 4Inventor of Green Catalysts Offers Solutions for Cleaning Toxins and Pollutants in the Environment 56443 1Inventor of Green Catalysts Offers Solutions for Cleaning Toxins and Pollutants in the Environment 56443 2BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury 4954 1BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury 4954 2
Other Medicine Technology:Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 2Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 3Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 4Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 5Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 6Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 7Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 8Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 2Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 3Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 4Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 5Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 6Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 7Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 8Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 9Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 10